Skip to main content
J

JIN YANG PHARMACEUTICAL. CO., LTD — Investor Relations & Filings

Ticker · 007370 ISIN · KR7007370000 KO Manufacturing
Open in API
Filings indexed 206 across all filing types
Latest filing 2026-03-27 Declaration of Voting R…
Country KR South Korea
Listing KO 007370

About JIN YANG PHARMACEUTICAL. CO., LTD

https://www.jinyangpharm.com/

JIN YANG PHARMACEUTICAL. CO., LTD. is a company engaged in the research, development, manufacturing, and sale of pharmaceutical products, with a primary focus on prescription drugs. The company operates a fully automated, high-tech manufacturing facility. Its research and development efforts are dedicated to creating advanced preventive and therapeutic treatments for various diseases. Key areas of R&D include the development of anticancer drugs through molecular biology research, particularly for leukemia, and therapies for metabolic disorders such as diabetes and obesity. The company also develops antivirals and explores formulations based on herbal preparations.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a detailed report of the resolutions and voting outcomes from the company's Annual General Meeting, listing each proposal’s approval status and vote percentages. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement.
2026-03-27 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Correction Report' (정정신고) for a 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집공고). It provides updated financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, and Cash Flow Statement) as part of the management's reference materials for the upcoming shareholder meeting. Since it is a formal regulatory filing detailing the agenda and financial disclosures for an AGM, it falls under the category of AGM Information.
2026-03-19 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Correction Report' (정정신고) for a 'Proxy Solicitation & Information Statement' (의결권대리행사권유참고서류) filed by Jinyang Pharmaceutical. It contains detailed financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, and Cash Flow Statement) as part of the proxy materials for an upcoming shareholder meeting. Since the primary purpose of the document is to provide information to shareholders to solicit their votes for the AGM, it is classified as a Proxy Solicitation & Information Statement.
2026-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Jinyang Pharmaceutical. It contains the auditor's opinion, key financial data (assets, liabilities, revenue, profit), and confirmation of the audit process. While it provides financial data, it is a regulatory filing specifically announcing the submission of the audit report to the exchange, which falls under the Audit Report/Information category. FY 2025
2026-03-18 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Jinyang Pharmaceutical Co., Ltd. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It covers the fiscal year ending December 31, 2025. Since it is a standalone audit report containing full financial statements and audit opinions, it is classified as an Audit Report (AR). FY 2025
2026-03-18 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard Korean regulatory filing used to provide shareholders with information regarding upcoming general meetings, including agenda items, board proposals, and financial summaries, to solicit their votes. This falls under the category of Proxy Solicitation & Information Statement.
2026-03-05 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.